Myworld
|
Sign Up
|
Login
Home
Browse
Featured
Latest
Popular
Templates
Patients
Blog
Dengue Fever
Send This
Download
Comment
Favourite
more
Add to your Conference/Group
Please Select--
Add your comments:
Rating :
Rate It:
Notes
Show Notes
Hide Notes
Slide 1 :
Dengue Fever Epidemiology and the Viruses Dr Wilson Lam Division of Infectious Diseases Department of Medicine QEH 3 June 2003
Slide 2 :
Dengue fever Dengue history The viruses and the vector Transmission of viruses Epidemiology Global Southeast Asia Hong Kong Epidemiological features DF DHF/DSS Reimmergence of dengue fever
Slide 3 :
Historical background Dengue like illness date back to more than 200 years ago 1779-1780 in Asia, Africa and North America Viral etiology established by the 1940s Global pandemic in Southeast Asia after World War II
Slide 4 :
Dengue viruses SS-RNA arbovirus (Flavivirus) 4 serotypes (DEN-1, 2, 3, 4) Based on envelop glycoprotein DEN-1 and 3 are more closely related DEN-4 less closely related to others Virulent variants (genotypes) within serotype Infection with any serotype confers specific lifelong immunity Transient cross-protection to other serotypes Any serotype can cause severe / fatal disease
Slide 5 :
Mosquito vectors All known vectors belong to genus Aedes Vector competence and vectorial capacity of different species vary Different species Different geographic populations of the same species No correlation between clinical features of subsequent disease
Slide 6 :
Mosquito vectors Subgenus Stegomyia contains the most important vectors of dengue viruses Ae. aegypti, Ae. albopictus and Ae. polynesiensis Ae. aegypti African origin Not found in Hong Kong Most important vectors worldwide Linked with human activities such as uncontrolled urbanization, deterioration of urban environment and decreasing standard of sanitation
Slide 7 :
Ae. Albopictus (1) Asian species South-East Asia, China, Japan, Indonesia, islands in the Indian Ocean, Hawaii Spreading to the United States, South America, Africa, the Pacific and south of europe Originally a forest mosquito feeding on a variety of animals and breeding in tree holes Become adapted to human environment Natural containers such as tree holes, plant axils, cut bamboo stumps and opened coconuts Outdoor artificial containers such as water storage barrels and trash receptacles
Slide 8 :
Ae. Albopictus (2) Can persist as far north as Beijing or Chicago (average isotherm of 0ºC) Optimal growth at 25 °C to 30°C Eggs can resist desiccation for several months 10 days for egg-larva-purpa-adult cycle Ae. albopictus females known to survive for up to 122 days (daily mortalities 8-15%)
Slide 9 :
Ae. Albopictus (3) Density much influenced by rainfall Feed outdoors during daytime Peak at 8-9 a.m. & 5-6 p.m. Multiple bites per feed Active maximum dispersal range of females about 400 to 600m Passive dispersal less important
Slide 10 :
Transmission of viruses Incubation Period: 3-14 days Viraemia & Fever: 5-7 days Vector Humidity: Rainfall & Temp. Susceptible hosts, (population) Source patients Extrinsic Incubation Period: 1-2 weeks
Slide 11 :
Slide 12 :
Transmission of viruses Extrinsic incubation period 10 to 14 days Depends on Ambient temperature Humidity Viraemic level in the human host Virus strains Intrinsic incubation period 4 to 7 days (Range 3-14 days) Viraemia may exist for 6 to 18 hours before onset of symptoms Symptomatic viraemic period is 4 to 5 days (up to 12 days)
Slide 13 :
At Risk Population: 2500 million Dengue cases / Yr.: 50 million (DHF: 500 000) Brazil 2001: 390,000 cases (670 DHF) Dengue fever endemic regions
Slide 14 :
Dengue in Southeast Asia WHO 2001
Slide 15 :
Stratification of DF/DHF in South-East Asia Region Category B (Bangladesh, India, Maldives, Sri Lanka) DHF is an emergent disease Cyclical epidemics are becoming more frequent Multiple virus serotypes circulating Expanding geographically within countries Aedes aegypti is the principal epidemic vector Role of Aedes albopictus is uncertain Category A (Indonesia, Myanmar, Thailand) Major public health problem Leading cause of hospitalization and death among children Cyclical epidemics in urban centres with 3-5 year periodicity Spreading to rural areas Multiple virus serotypes circulating Aedes aegypti is the principal epidemic vector Role of Aedes albopictus is uncertain
Slide 16 :
DF – Macau 1,502 cases in 2001 mostly indigenous First 14 cases reported in late August 2001 Last case in December All were minor cases without complications Origin and cause unknown Mostly serotype DEN-2 (2 cases of DEN-1) Up to end September 2002 Only 1 imported case (Thailand)
Slide 17 :
DF – Hong Kong 2002
Slide 18 :
DF – Hong Kong 2002
Slide 19 :
Dengue in Hong Kong From 1994 to 2001, inclusive Cases: DF (68), DHF (4) All were imported cases Peak incidence at September (?return from travel) 2002 (up to 19 October) 20 indigenous cases all DF, aged 20 to 72 yrs., Male: 13 16 cases related to Ma Wan (6 residents, 10 CSW) onset: early July to 25 September All except one, were DEN-1 index case was suspected on 19 Sep. 2002 HK strains were different phylogenetically from Macau strains.
Slide 20 :
DF – Hong Kong 2003
Slide 21 :
Epidemiological features Dengue fever (DF) Dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) DHF is not DF with haemorrhagic features
Slide 22 :
DF – epidemiology Spread Endemic or epidemic Travel along transportation routes First appears in seaport and airport cities
Slide 23 :
DF – epidemiology Seasonality Usually rainy seasons Vectors, such as Ae. albopictus, that have outdoor larval habitats more affected by rainfall High humidity Longer mosquito survival High temperature Vector distribution Adult longevity Shorter extrinsic incubation period Smaller females – more blood meals Water cooler recirculation troughs during dry seasons
Slide 24 :
DF – epidemiology Severity Vary in rate of transmission, percentage of population involved and clinical severity Age Pre-adolescent children less severe Nearly all adults overt illness Immune status Highly immune population less reported disease
Slide 25 :
DF – epidemiology Severity Ethnicity Strain variation Disease severity and haemorrhagic phenomenon vary from outbreak to outbreak Unique serotype or viral strain-specific factors Level of circulating viruses
Slide 26 :
DF – epidemiology Age/sex Mostly adults Adult women and pre-school children in some outbreaks Transmission by daytime-biting
Slide 27 :
Dengue Hemorrhagic Fever (DHF) Fever, or recent history of acute fever Hemorrhagic manifestations (grade I & II) Low platelet count (?100,000/mm3) Objective evidence of “leaky capillaries:” elevated hematocrit (?20% over baseline) low albumin / hypoproteinaemia pleural or other effusions 4 Necessary Criteria (WHO): First recognized in the Philippines in 1953
Slide 28 :
Dengue Shock Syndrome (DSS) 4 criteria for DHF Evidence of circulatory failure: Rapid and weak pulse Narrow pulse pressure (? 20 mm Hg) OR hypotension for age Cold, clammy skin/altered mental status (grade III) or profound Shock (grade IV)
Slide 29 :
DHF/DSS – epidemiology Early reports 1897 Northern Australia 1928 Greece 1935 Taiwan 1950 Thailand mid-1980s Southern China and Hainan Island Asian DHF/DSS epidemics Multiple types of dengue viruses simultaneously or sequentially endemic Secondary-type antibody responses observed Only during secondary dengue infections
Slide 30 :
DHF/DSS epidemiology Infection parity and enhancing antibodies Secondary-type dengue infections Primary in infants born to dengue-immune mothers Antigens shared between first and second infecting serotypes Shift the spectrum towards more severe disease
Slide 31 :
DHF/DSS epidemiology Pathogenesis of antibody dependent enhancement Serum antibodies developed can neutralize dengue virus of that same serotype (homologous) Pre-existing heterologous antibodies form complexes but no neutralization Infected monocytes release vasoactive mediators Increased vascular permeability Haemorrhagic manifestations
Slide 32 :
Slide 33 :
Slide 34 :
Slide 35 :
DHF/DSS epidemiology Protective antibodies Low levels of cross-reactvie neutralizing antibody protect against DHF/DSS Different viral antigens? Epitopes closely similar to serotype-specific neutralizing epitopes of another virus Different host response? Human immune system responds differently to a single specific repertoire
Slide 36 :
DHF/DSS epidemiology Viral strain Severity Viruses which causes mild and severe disease appear genetically identical Occurrence or non-occurrence Only dengue viruses of Asian origins at epidemic proportion Distribution of heterotypic and non-heterotypic antigens
Slide 37 :
DHF/DSS epidemiology Age Greatest susceptibility to shock is 8 to 10 years ? Capillaries of of children more prone to cytokine-mediated increased permeability Sex Shock cases and deaths more frequently in female than in male children ? Immune responses of females more competent ? Capillary bed of females more prone to increased capillary permeability
Slide 38 :
DHF/DSS epidemiology Nutritional status Moderate to severe protein-calorie malnutrition reduces risk to DHF/DSS in dengue infected children Malnutrition suppresses cellular immune responses Preceding host conditions Peptic ulcer and menstrual periods risk factors for severe bleeding
Slide 39 :
Reemergence of DF/DHF Unprecedented human population growth Unplanned and uncontrolled urbanization Inadequate waste management and water supply Increased distribution and densities of vector mosquitoes Lack of effective mosquito control Increased movement and spread of dengue viruses
Slide 40 :
Thank you!
Slide 41 :
Dengue Fever: Case Definition For Epidemiological Purposes: Suspected case: An acute febrile illness characterized by intense headache, retro-orbital pain, myalgia, arthralgia, rash, leucopenia or haemorrhagic manifestations. Probable case: A clinically compatible case with supportive serology. Confirmed case: A clinically compatible case with laboratory confirmation.
Slide 42 :
Supportive serologic findings: An antibody titer of ?1280 or a positive IgM antibody test on a single serum sample to Dengue antigen. Criteria for laboratory confirmation: (? one) Isolation of Dengue virus from patient samples; A ?4x change in antibody titers to Dengue antigens in paired serum samples; Detection of Dengue virus genomic sequences patient samples by PCR. Laboratory support for case definition
Slide :
Slide 44 :
Virological Diagnosis Dengue-specific tests Virus isolation Serology HAI IgM Immunochromatographic IgM EIA Real Time - PCR
Slide 45 :
Rapid Strip Test: False Positives BOOK K M EBV IgM +ve Sequential testing or confirmation is required.
Slide 46 :
Rapid Strip Test: False Positives Fever for 2 weeks Live in Sai Kung area Cleaning work headache, skin rash, myalgia, hearing impairment Fundi: haemorrhage ALT: 561, Chest: basal crepitations prolonged PT/APTT Weil-Felix: OX-K 1:640
Slide 47 :
Ovitrap index Ovitrap black container, with rough surface, water placed 1m above the ground, 100m apart 50 traps in an area of 0.5 km2 incubate for 1 week at 25°C Index the % of trap showing Aedes albopictus larva reflects the extent (but not the density) of infestation.
Slide 48 :
Ovitrap in hospital area
Slide 49 :
Sing Pao 20 Oct 2002 Press Release FEHD December 21, 2002 Ovitrap index in Hong Kong
Slide 50 :
Control of Dengue Fever Statutory Notification since 1994 Laboratory surveillance Active case finding Self-reporting (DH hotline: 2961 8966) Global surveillance Case investigation Information dissemination
Slide 51 :
Control of Dengue Fever Case investigation confirm diagnosis travel history local movement potential mosquito breeding sites S/S among travel & local collaterals medical surveillance of collaterals
Slide 52 :
Blood Transfusion transmitted DF Donor: M/17 lives in Ma Wan. Date of donation: 17/07/2002 well and asymptomatic attended YCH AED on 24 July, DX: Viral rash ? DF during case finding exercise in Ma Wan in October blood
There is no comments now for this Slide.
Post a comment
Post Comment on Twitter
Post Comment on SlideWorld
Comments:
Subscribe to follow-up comments
SlideWorld will not store your password. SlideWorld will maintain your privacy.
Twitter Username:
Twitter Password:
Comments:
Email:
Subscribe to follow-up comments
Fever and Rash Nurs...
Costeffectiveness of...
Syndromic Management...
Antibody response in...
fever a clinical app...
Clinical profile of ...
Free Powerpoint Templates
SlidesOnline
4 Years ago.
Category:
General
Tags:
other
6328 Views, 1 favourite
No correlation between clinical features of subsequent disease. Mosquito vectors .... Peptic ulcer
more
No correlation between clinical features of subsequent disease. Mosquito vectors .... Peptic ulcer and menstrual periods risk factors for severe bleeding
less
Browse
|
Powerpoint Templates
|
Tags
|
Contact
|
About Us
|
Privacy
|
FAQ
|
Blog
© Slideworld